SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?


To: Zvi Steinberg who wrote (1289)9/26/1998 11:55:00 PM
From: Ariella  Read Replies (1) | Respond to of 1491
 
Dear Zvi -- thanks for posting update to web page. Nachshon Knoller is the lead writer, a neurosurgeon, on the material about dexanabinol that went into Lancet. One great thing -- he knows how to speak in compelling "sound bites."

He's the one quoted as saying: <<If it {HU-211) is successful it might become a "standard inclusion in the kit bag of every medic and ambulance." >>

Sounds pretty good to me!
Ariella ;-)